Segment information

3 Months Ended

Oct. 31, 2017

14. Segment information

Our business is strategically aligned into three segments: Medical Imaging, Ultrasound, and Security and Detection. Our business segments are described as follows:

•

Medical Imaging primarily includes systems and subsystems for CT and MRI medical imaging equipment as well as state-of-the-art, selenium-based detectors for screening of breast cancer and other diagnostic applications in mammography.

•

Ultrasound includes ultrasound systems and transducers primarily in the urology, surgery, and Anesthesia markets.

•

Security and Detection includes advanced threat detecting CT systems utilizing our expertise in advanced imaging technology, primarily used in the checked baggage screening at airports worldwide.

The tables below present information about our reportable segments:

	Three Months Ended
	October 31,
(in millions)	2017		2016
Product revenue:
Medical Imaging	$	52.0	$	66.5
Ultrasound		37.4		35.6
Security and Detection		16.4		18.1
Total product revenue	$	105.8	$	120.2
Engineering revenue:
Medical Imaging	$	1.1	$	0.7
Ultrasound		-		0.2
Security and Detection		-		-
Total engineering revenue	$	1.1	$	0.9
Net revenue:
Medical Imaging	$	53.1	$	67.2
Ultrasound		37.4		35.8
Security and Detection		16.4		18.1
Total net revenue	$	106.9	$	121.1
Income (loss) from operations:
Medical Imaging (A)	$	4.8	$	6.7
Ultrasound (B)		1.3		(5.8	)
Security and Detection		1.8		3.0
Total income from operations		7.9		3.9
Total other income (loss), net		0.2		(0.4	)
Income before income taxes	$	8.1	$	3.5

	As of		As of
	October 31,		July 31,
(in millions)	2017		2017
Identifiable total assets by segment:
Medical Imaging	$	159.6	$	169.1
Ultrasound		132.7		133.6
Security and Detection		39.7		36.0
Total reportable segment assets		332.0		338.7
Corporate assets (C)		203.0		197.0
Total identifiable assets	$	535.0	$	535.7

(A)	Includes restructuring charges of $0.1 million and $0.02 million for the three months ended October 31, 2017 and 2016, respectively.

(B)	Includes restructuring charges of $0.4 million and $0.01 million for the three months ended October 31, 2017 and 2016, respectively.

(C)	Includes cash and cash equivalents of $132.6 million and $135.2 million as of October 31, 2017 and July 31, 2017, respectively.